AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21518924 — intervention group
Group type: COMPARATOR
Intervention: ΔSUVmaxPET0-2 (≤ 66%)
Number of subjects: 85
Study 21518924 — intervention group
Group type: EXPERIMENTAL
Intervention: ΔSUVmaxPET0-4 (> 70%)
Number of subjects: 85
Study 21518924 — intervention group
Group type: COMPARATOR
Intervention: ΔSUVmaxPET0-4 (≤ 70%)
Number of subjects: 85
Study 18294568 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 3557
Study 18294568 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy (secondary prevention)
Number of subjects: 3557
Study 18294568 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy (new-onset or postoperative AF)
Number of subjects: 3557
Study 16808579 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuji Ortho LC (RMGIC)
Number of subjects: 60
Study 16808579 — intervention group
Group type: COMPARATOR
Intervention: APC bracket (resin)
Number of subjects: 60
Study 14640133 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump coronary artery bypass (OPCAB)
Number of subjects: 20
Study 14640133 — intervention group
Group type: COMPARATOR
Intervention: CABG with cardiopulmonary bypass (CPB)
Number of subjects: 20
Study 10780036 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 20
Study 10780036 — intervention group
Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 20
Study 10780036 — intervention group
Group type: COMPARATOR
Intervention: Prone position
Number of subjects: 20
Study 8837910 — intervention group
Group type: EXPERIMENTAL
Intervention: Education group
Number of subjects: 0
Study 8837910 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 0
Study 1339211 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTH stimulation in tubercular patients
Number of subjects: 28
Study 1339211 — intervention group
Group type: COMPARATOR
Intervention: Healthy individuals (control group)
Number of subjects: 28
Study 6536513 — intervention group
Group type: COMPARATOR
Intervention: Control (Group I: no glycopyrrolate or cimetidine)
Number of subjects: 96
Study 6536513 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate (Group II: 5 micrograms kg‐1 intramuscularly in a.m.)
Number of subjects: 96
Study 6536513 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (Group III: 5 mg kg‐1 orally in a.m.)
Number of subjects: 96
Study 6536513 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (Group IV: 5 mg kg‐1 orally in a.m. and glycopyrrolate 5 micrograms kg‐1 in a.m.)
Number of subjects: 96
Study 6536513 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (Group V: 5 mg kg‐1 orally h.s. and a.m.)
Number of subjects: 96
Study 6536513 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (Group VI: as in Group V and glycopyrrolate as in Group II)
Number of subjects: 96
Study 30730980 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse childhood experiences (ACEs)
Number of subjects: 1501
Study 30419931 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice cognitive control by delaying their first cigarette of the day for 2 weeks
Number of subjects: 80
Study 30419931 — intervention group
Group type: COMPARATOR
Intervention: Monitoring only (no practice group)
Number of subjects: 80
Study 26684960 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-delivered intervention (Alcohol-Wise)
Number of subjects: 58
Study 26684960 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 58
Study 25248854 — intervention group
Group type: EXPERIMENTAL
Intervention: Presentation encouraging employers to purchase a high quality depression product with a return on investment estimate
Number of subjects: 293
Study 25248854 — intervention group
Group type: COMPARATOR
Intervention: Usual care presentation encouraging employers to work with their health plan to improve depression treatment quality indicators
Number of subjects: 293
Study 22752636 — intervention group
Group type: EXPERIMENTAL
Intervention: GFD + prednisolone (1 mg/kg for 4 weeks, n = 16)
Number of subjects: 33
Study 22752636 — intervention group
Group type: COMPARATOR
Intervention: GFD (n = 17)
Number of subjects: 33
Study 22752636 — intervention group
Group type: EXPERIMENTAL
Intervention: GFD + prednisolone (1 mg/kg for 4 weeks)
Number of subjects: 33
Study 20472748 — intervention group
Group type: EXPERIMENTAL
Intervention: 180° SLT
Number of subjects: 40
Study 20472748 — intervention group
Group type: EXPERIMENTAL
Intervention: 360° SLT
Number of subjects: 40
Study 20472748 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated eyes)
Number of subjects: 40
Study 18550198 — intervention group
Group type: EXPERIMENTAL
Intervention: KRM group (AST-120)
Number of subjects: 16
Study 18550198 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study 16019771 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride (3 months pretreatment)
Number of subjects: 35
Study 16019771 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 months pretreatment)
Number of subjects: 35
Study 12203177 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral acetazolamide
Number of subjects: 22
Study 12203177 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 10609766 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients (Group A)
Number of subjects: 673
Study 10609766 — intervention group
Group type: COMPARATOR
Intervention: Nondiabetic patients (Group B)
Number of subjects: 673
Study 8604367 — intervention group
Group type: EXPERIMENTAL
Intervention: Special care unit (SCU) for chronically critically ill patients
Number of subjects: 0
Study 8604367 — intervention group
Group type: COMPARATOR
Intervention: Traditional ICU
Number of subjects: 0
Study 8604367 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall patient population
Number of subjects: 0
Study 1941059 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive cytarabine and daunorubicin (DNR)
Number of subjects: 151
Study 1941059 — intervention group
Group type: COMPARATOR
Intervention: Cycles of mercaptopurine (6‐MP) and methotrexate (MTX), followed by 6MP, MTX, vincristine (VCR), and prednisone for 3 years
Number of subjects: 151
Study 7150496 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of fenoterol aerosol (400 micrograms)
Number of subjects: 19
Study 7150496 — intervention group
Group type: EXPERIMENTAL
Intervention: Buccal administration of fenoterol (400 micrograms)
Number of subjects: 19
Study 29979882 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy‐Adolescent Skills Training (IPT‐AST; n = 95)
Number of subjects: 186
Study 29979882 — intervention group
Group type: COMPARATOR
Intervention: Group Counseling (GC; n = 91)
Number of subjects: 186
Study 29912955 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA
Number of subjects: 132
Study 27871538 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1‐μg/kg load followed by 1‐μg/(kg h) infusion
Number of subjects: 40
Study 27871538 — intervention group
Group type: COMPARATOR
Intervention: Propofol infusion at 300 μg/(kg min) reduced to 250‐μg/(kg min) infusion
Number of subjects: 40
Study 24291194 — intervention group
Group type: EXPERIMENTAL
Intervention: HOWARU(®) Restore probiotic 1.70×10(10) CFU (high-dose, n=168)
Number of subjects: 503
Study 24291194 — intervention group
Group type: EXPERIMENTAL
Intervention: HOWARU(®) Restore probiotic 4.17×10(9) CFU (low-dose, n=168)
Number of subjects: 503
Study 24291194 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=167)
Number of subjects: 503
Study 22580935 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval training on VR simulation over 3 days
Number of subjects: 40
Study 22580935 — intervention group
Group type: COMPARATOR
Intervention: Massed training on VR simulation in 1 day
Number of subjects: 40
Study 22580935 — intervention group
Group type: COMPARATOR
Intervention: Control condition performing laparoscopic assessment task
Number of subjects: 40
Study 22580935 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice condition with 1 complete practice trial on the simulator
Number of subjects: 40
Study 22580935 — intervention group
Group type: COMPARATOR
Intervention: No-practice condition
Number of subjects: 40
Study 20236345 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen sodium
Number of subjects: 16
Study 17608817 — intervention group
Group type: EXPERIMENTAL
Intervention: Pituitary disease patients
Number of subjects: 86
Study 17608817 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocrine disease patients (pituitary or nonpituitary)
Number of subjects: 86
Study 17608817 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 86
Study 17608817 — intervention group
Group type: COMPARATOR
Intervention: Nonpituitary endocrine patients
Number of subjects: 86
Study 15836978 — intervention group
Group type: EXPERIMENTAL
Intervention: Noxious stimulation (30% above pain threshold)
Number of subjects: 4
Study 15836978 — intervention group
Group type: EXPERIMENTAL
Intervention: Innocuous stimulation (30% below pain threshold)
Number of subjects: 4
Study 15836978 — intervention group
Group type: EXPERIMENTAL
Intervention: Noxious stimulation
Number of subjects: 4
Study 15836978 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 4
Study 15836978 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 4
Study 12046068 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative regional artery chemotherapy (PRACT)
Number of subjects: 110
Study 10459075 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative oral carbohydrate administration (CHO-H)
Number of subjects: 16
Study 10459075 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink (placebo)
Number of subjects: 16
Study 10459075 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative oral carbohydrate administration (CHO-C)
Number of subjects: 16
Study 10459075 — intervention group
Group type: COMPARATOR
Intervention: Fasted group
Number of subjects: 16
Study 7608279 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Arginine infusion (500 mg/kg over 30 min)
Number of subjects: 10
Study 7608279 — intervention group
Group type: COMPARATOR
Intervention: Saline vehicle
Number of subjects: 10
Study 2193166 — intervention group
Group type: EXPERIMENTAL
Intervention: Megestrol acetate (800 mg per day)
Number of subjects: 133
Study 2193166 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study 499288 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral aminophylline 500 mg
Number of subjects: 12
Study 499288 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophylline suppository 500 mg
Number of subjects: 12
Study 499288 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30999952 — intervention group
Group type: COMPARATOR
Intervention: SMS text message intervention plus Treatment As Usual (TAU) receiving nine SMS text messages at 1, 2, 3, 4, 5, 6, 8, 10 and 12 months post-discharge.
Number of subjects: 0
Study 30999952 — intervention group
Group type: COMPARATOR
Intervention: Treatment As Usual (TAU) alone.
Number of subjects: 0
Study 27917593 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological treatment 1
Number of subjects: 0
Study 27917593 — intervention group
Group type: COMPARATOR
Intervention: Pharmacological treatment 2
Number of subjects: 0
Study 25935596 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylaminolevulinate photodynamic therapy (MAL-PDT)
Number of subjects: 336
Study 25935596 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod
Number of subjects: 336
Study 25935596 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (FU)
Number of subjects: 336
Study 25935596 — intervention group
Group type: COMPARATOR
Intervention: Control group (tumors without treatment failure)
Number of subjects: 336
Study 23390125 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 0
Study 23390125 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 0
Study 20881878 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine (5 g·d)
Number of subjects: 25
Study 20881878 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 19563393 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg and Simvastatin 10 mg daily (E10/S10)
Number of subjects: 36
Study 19563393 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg daily (S80)
Number of subjects: 36
Study 16452264 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment of medial collateral ligament injury (n = 23)
Number of subjects: 47
Study 16452264 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment of medial collateral ligament injury (n = 24)
Number of subjects: 47
Study 15623698 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-motor intervention (CMI) with psychosocial support
Number of subjects: 84
Study 15623698 — intervention group
Group type: COMPARATOR
Intervention: Psychosocial support alone (control group)
Number of subjects: 84
Study 11353935 — intervention group
Group type: EXPERIMENTAL
Intervention: BIPAP (n = 11)
Number of subjects: 18
Study 11353935 — intervention group
Group type: COMPARATOR
Intervention: Assisted spontaneous breathing (ASB) (n = 7)
Number of subjects: 18
Study 10963910 — intervention group
Group type: EXPERIMENTAL
Intervention: Stages of change questionnaire
Number of subjects: 177
Study 8972892 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (12.5 to 50 mg twice daily)
Number of subjects: 149
Study 8972892 — intervention group
Group type: COMPARATOR
Intervention: Beta-blockers (atenolol: 25 to 100 mg once daily or propranolol: 10 to 80 mg twice daily)
Number of subjects: 149
Study 1292407 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoxygenation with 50% oxygen and nitrous oxide
Number of subjects: 65
Study 1292407 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoxygenation with 100% oxygen
Number of subjects: 65
Study 1292407 — intervention group
Group type: COMPARATOR
Intervention: No preoxygenation (Control Group)
Number of subjects: 65
Study 6467836 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine rest for 20 minutes followed by standing transition
Number of subjects: 0
Study 6467836 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine rest for 1 minute followed by standing transition
Number of subjects: 0
Study 6467836 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-up tilt after supine rest
Number of subjects: 0
Study 30503307 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flexion mobile-bearing TKA
Number of subjects: 164
Study 30503307 — intervention group
Group type: COMPARATOR
Intervention: High-flexion fixed-bearing TKA
Number of subjects: 164
Study 30503307 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 164
Study 29727039 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes with microvascular complications
Number of subjects: 2707
Study 29727039 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes without microvascular complications
Number of subjects: 2707
Study 29727039 — intervention group
Group type: COMPARATOR
Intervention: No diabetes
Number of subjects: 2707
Study 26861976 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA topical anaesthetic (2.5% lidocaine and 2.5% prilocaine)
Number of subjects: 11
Study 26861976 — intervention group
Group type: EXPERIMENTAL
Intervention: Ametop topical anaesthetic (4% tetracaine)
Number of subjects: 11
Study 24379278 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretic efficiency (DE) estimated as net fluid output produced per 40 mg of furosemide equivalents, dichotomized into high versus low DE.
Number of subjects: 1047
Study 24379278 — intervention group
Group type: COMPARATOR
Intervention: Traditional baseline characteristics and metrics of renal function and preadmission diuretic therapy.
Number of subjects: 1047
Study 22679721 — intervention group
Group type: EXPERIMENTAL
Intervention: Huzhang Tongfeng Granule (HTG), diclofenac sodium extended‐release capsule, Jinhuang Ointment (JO) in the acute stage; Yinlian Tongfeng Granule (YTG) and Benzbromarone Tablet (BT) in the intermission stage.
Number of subjects: 120
Study 22679721 — intervention group
Group type: COMPARATOR
Intervention: diclofenac sodium extended‐release capsule in the acute stage; Benzbromarone Tablet (BT) in the intermission stage.
Number of subjects: 120
Study 20140407 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based motor training programme once a week for 8 consecutive weeks
Number of subjects: 23
Study 20140407 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual-based motor training programme once a week for 8 consecutive weeks
Number of subjects: 23
Study 20140407 — intervention group
Group type: COMPARATOR
Intervention: Group-based training
Number of subjects: 23
Study 20140407 — intervention group
Group type: COMPARATOR
Intervention: Individual-based training
Number of subjects: 23
Study 17071931 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP)
Number of subjects: 79
Study 17071931 — intervention group
Group type: COMPARATOR
Intervention: Mitoxantrone, Chlorambucil, Prednisone (MCP)
Number of subjects: 79
Study 16267764 — intervention group
Group type: EXPERIMENTAL
Intervention: Efavirenz
Number of subjects: 504
Study 16267764 — intervention group
Group type: EXPERIMENTAL
Intervention: Nelfinavir
Number of subjects: 504
Study 12015533 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking at enrollment
Number of subjects: 4589
Study 12015533 — intervention group
Group type: COMPARATOR
Intervention: Quit smoking before LMP
Number of subjects: 4589
Study 9792265 — intervention group
Group type: EXPERIMENTAL
Intervention: Wavelet decomposition analysis
Number of subjects: 246
Study 9792265 — intervention group
Group type: COMPARATOR
Intervention: Patients dying non-suddenly
Number of subjects: 246
Study 8533562 — intervention group
Group type: EXPERIMENTAL
Intervention: SFM (casual sex with foreign males)
Number of subjects: 996
Study 2403484 — intervention group
Group type: COMPARATOR
Intervention: Ticarcillin‐clavulanate plus vancomycin (TV)
Number of subjects: 535
Study 2403484 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime plus vancomycin (CV)
Number of subjects: 535
Study 2403484 — intervention group
Group type: EXPERIMENTAL
Intervention: All three antibiotics (TCV)
Number of subjects: 535
Study 31830292 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical citicoline eye drops three times a day for 1 month
Number of subjects: 78
Study 31830292 — intervention group
Group type: COMPARATOR
Intervention: Lubricant hyaluronic acid (0.15%) eye drops three times a day for 1 month
Number of subjects: 78
Study 28071649 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.5‐h sleep duration
Number of subjects: 9
Study 28071649 — intervention group
Group type: COMPARATOR
Intervention: 7‐h sleep duration
Number of subjects: 9
Study 26115112 — intervention group
Group type: EXPERIMENTAL
Intervention: Didactic lecture
Number of subjects: 496
Study 26115112 — intervention group
Group type: EXPERIMENTAL
Intervention: Brainstorming workshop
Number of subjects: 496
Study 26115112 — intervention group
Group type: COMPARATOR
Intervention: Control group (delayed education)
Number of subjects: 496
Study 23948533 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher perceived drinking peer norms
Number of subjects: 193
Study 23948533 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived drinking norms
Number of subjects: 193
Study 21304094 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 9978
Study 21304094 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 9978
Study 19801056 — intervention group
Group type: EXPERIMENTAL
Intervention: Arc‐RADs
Number of subjects: 16
Study 19801056 — intervention group
Group type: COMPARATOR
Intervention: C‐RADs
Number of subjects: 16
Study 16954488 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational outreach visits (1 hour)
Number of subjects: 6451
Study 16954488 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 6451
Study 15178665 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 850 mg twice daily
Number of subjects: 40
Study 15178665 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 11430565 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (5 mg at 09:00 and 2.5 mg at 14:00)
Number of subjects: 14
Study 11430565 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.5 mg at 23:00) with prednisolone (2.5 mg at 14:00)
Number of subjects: 14
Study 11430565 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy volunteers)
Number of subjects: 14
Study 9409140 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 months outpatient treatment (experimental group)
Number of subjects: 230
Study 9409140 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 months outpatient treatment (experimental group)
Number of subjects: 230
Study 9409140 — intervention group
Group type: COMPARATOR
Intervention: Control group (3 months treatment)
Number of subjects: 230
Study 9409140 — intervention group
Group type: COMPARATOR
Intervention: Control group (6 months treatment)
Number of subjects: 230
Study 9409140 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 230
Study 7968645 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose oral contraceptive (30 mcg ethinyl estradiol plus 75 mcg gestodene)
Number of subjects: 16
Study 7968645 — intervention group
Group type: COMPARATOR
Intervention: Calcium supplementation (500 mg/day)
Number of subjects: 16
Study 3115455 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer based system for dietary assessment
Number of subjects: 50
Study 3115455 — intervention group
Group type: COMPARATOR
Intervention: Dietary history method
Number of subjects: 50
Study 3115455 — intervention group
Group type: COMPARATOR
Intervention: Food tables for nutrient calculation
Number of subjects: 50
Study 30277890 — intervention group
Group type: EXPERIMENTAL
Intervention: Low tidal volume-airway pressure release ventilation
Number of subjects: 52
Study 30277890 — intervention group
Group type: EXPERIMENTAL
Intervention: Airway pressure release ventilation
Number of subjects: 52
Study 30277890 — intervention group
Group type: COMPARATOR
Intervention: Volume control
Number of subjects: 52
Study 30277890 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 3 PaO2/FIO2
Number of subjects: 52
Study 30277890 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedation, vasoactive medications, or occurrence of pneumothorax
Number of subjects: 52